177 related articles for article (PubMed ID: 32377945)
1. Interleukin-35 promotes the differentiation of regulatory T cells and suppresses Th2 response in IgG4-related type 1 autoimmune pancreatitis.
Ito T; Tanaka T; Nakamaru K; Tomiyama T; Yamaguchi T; Ando Y; Ikeura T; Fukui T; Uchida K; Nishio A; Okazaki K
J Gastroenterol; 2020 Aug; 55(8):789-799. PubMed ID: 32377945
[TBL] [Abstract][Full Text] [Related]
2. Identification of serum IFN-α and IL-33 as novel biomarkers for type 1 autoimmune pancreatitis and IgG4-related disease.
Minaga K; Watanabe T; Hara A; Kamata K; Omoto S; Nakai A; Otsuka Y; Sekai I; Yoshikawa T; Yamao K; Takenaka M; Chiba Y; Kudo M
Sci Rep; 2020 Sep; 10(1):14879. PubMed ID: 32938972
[TBL] [Abstract][Full Text] [Related]
3. Serum free light chain assessment in type 1 autoimmune pancreatitis.
Ikemune M; Uchida K; Tsukuda S; Ito T; Nakamaru K; Tomiyama T; Ikeura T; Naganuma M; Okazaki K
Pancreatology; 2021 Apr; 21(3):658-665. PubMed ID: 33741268
[TBL] [Abstract][Full Text] [Related]
4. Involvement of inducible costimulator- and interleukin 10-positive regulatory T cells in the development of IgG4-related autoimmune pancreatitis.
Kusuda T; Uchida K; Miyoshi H; Koyabu M; Satoi S; Takaoka M; Shikata N; Uemura Y; Okazaki K
Pancreas; 2011 Oct; 40(7):1120-30. PubMed ID: 21926547
[TBL] [Abstract][Full Text] [Related]
5. Circulating naïve and CD4+CD25high regulatory T cells in patients with autoimmune pancreatitis.
Miyoshi H; Uchida K; Taniguchi T; Yazumi S; Matsushita M; Takaoka M; Okazaki K
Pancreas; 2008 Mar; 36(2):133-40. PubMed ID: 18376303
[TBL] [Abstract][Full Text] [Related]
6. Possible involvement of CCL1-CCR8 interaction in lymphocytic recruitment in IgG4-related sclerosing cholangitis.
Zen Y; Liberal R; Nakanuma Y; Heaton N; Portmann B
J Hepatol; 2013 Nov; 59(5):1059-64. PubMed ID: 23811304
[TBL] [Abstract][Full Text] [Related]
7. Plasmacytoid Dendritic Cells as a New Therapeutic Target for Autoimmune Pancreatitis and IgG4-Related Disease.
Minaga K; Watanabe T; Hara A; Yoshikawa T; Kamata K; Kudo M
Front Immunol; 2021; 12():713779. PubMed ID: 34367181
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-35 Promotes Th9 Cell Differentiation in IgG4-Related Disorders: Experimental Data and Review of the Literature.
Zhang J; Lian M; Li B; Gao L; Tanaka T; You Z; Wei Y; Chen Y; Li Y; Li Y; Huang B; Tang R; Wang Q; Miao Q; Peng Y; Fang J; Lian Z; Okazaki K; Xiao X; Zhang W; Ma X
Clin Rev Allergy Immunol; 2021 Feb; 60(1):132-145. PubMed ID: 32712804
[TBL] [Abstract][Full Text] [Related]
9. Amount of CD4+CD25+ regulatory T cells in autoimmune pancreatitis and pilonidal sinus.
Fukumura Y; Takase M; Mitani K; Suda K; Imamhasan A; Nobukawa B; Ueda A; Abe H; Yao T
Pancreas; 2012 Aug; 41(6):910-5. PubMed ID: 22466163
[TBL] [Abstract][Full Text] [Related]
10. Biomarkers in autoimmune pancreatitis and immunoglobulin G4-related disease.
Hara A; Watanabe T; Minaga K; Yoshikawa T; Kamata K; Kudo M
World J Gastroenterol; 2021 May; 27(19):2257-2269. PubMed ID: 34040320
[TBL] [Abstract][Full Text] [Related]
11. Intestinal Dysbiosis and Autoimmune Pancreatitis.
Yoshikawa T; Watanabe T; Kamata K; Hara A; Minaga K; Kudo M
Front Immunol; 2021; 12():621532. PubMed ID: 33833754
[TBL] [Abstract][Full Text] [Related]
12. Mechanistic Insights into Autoimmune Pancreatitis and IgG4-Related Disease.
Watanabe T; Minaga K; Kamata K; Kudo M; Strober W
Trends Immunol; 2018 Nov; 39(11):874-889. PubMed ID: 30401468
[TBL] [Abstract][Full Text] [Related]
13. Activated T-Follicular Helper 2 Cells Are Associated With Disease Activity in IgG4-Related Sclerosing Cholangitis and Pancreatitis.
Cargill T; Makuch M; Sadler R; Lighaam LC; Peters R; van Ham M; Klenerman P; Bateman A; Rispens T; Barnes E; Culver EL
Clin Transl Gastroenterol; 2019 Apr; 10(4):e00020. PubMed ID: 31033594
[TBL] [Abstract][Full Text] [Related]
14. Clinical and pathophysiological aspects of type 1 autoimmune pancreatitis.
Uchida K; Okazaki K
J Gastroenterol; 2018 Apr; 53(4):475-483. PubMed ID: 29460239
[TBL] [Abstract][Full Text] [Related]
15. Recent advances in IgG4-related autoimmune pancreatitis.
Yang X; Zhou H; Wang W; Yan C; Ji G
Pathol Res Pract; 2024 May; 257():155331. PubMed ID: 38678849
[TBL] [Abstract][Full Text] [Related]
16. Combination of autoimmune pancreatitis and peripheral neuropathy on an IgG4-related disease patient with 4 years following-up.
Zhan L; Fan M; Cai N; Cai B
J Neuroimmunol; 2020 Nov; 348():577378. PubMed ID: 32949993
[TBL] [Abstract][Full Text] [Related]
17. Th2 and regulatory immune reactions are increased in immunoglobin G4-related sclerosing pancreatitis and cholangitis.
Zen Y; Fujii T; Harada K; Kawano M; Yamada K; Takahira M; Nakanuma Y
Hepatology; 2007 Jun; 45(6):1538-46. PubMed ID: 17518371
[TBL] [Abstract][Full Text] [Related]
18. The role of CD19+ CD24high CD38high and CD19+ CD24high CD27+ regulatory B cells in patients with type 1 autoimmune pancreatitis.
Sumimoto K; Uchida K; Kusuda T; Mitsuyama T; Sakaguchi Y; Fukui T; Matsushita M; Takaoka M; Nishio A; Okazaki K
Pancreatology; 2014; 14(3):193-200. PubMed ID: 24854615
[TBL] [Abstract][Full Text] [Related]
19. Is autoimmune pancreatitis a risk factor for pancreatic adenocarcinoma?
Kunovský L; Dítě P; Blaho M; Dvořáčková J; Uvírová M; Přecechtělová M; Jabandžiev P; Mašková H; Kianička B; Janeček P; Eid M; Martínek A
Vnitr Lek; 2021; 67(1):9-13. PubMed ID: 33752395
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of swollen duodenal papilla in autoimmune pancreatitis.
Kubota K; Iida H; Fujisawa T; Ogawa M; Inamori M; Saito S; Kakuta Y; Oshiro H; Nakajima A
Pancreas; 2007 Nov; 35(4):e51-60. PubMed ID: 18090232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
